Literature DB >> 12048346

Interleukin-18 and host defense against infectious pathogens.

Kazuyoshi Kawakami1.   

Abstract

Host defense to infectious pathogens is largely mediated by neutrophil-, cellular, or humoral immunity or eosinophil-dependent mechanism. Each mechanism preferentially acts against extracellular or intracellular microbial pathogens, viruses, or helminthes. These host defense responses are strictly regulated by two different categories of cytokines, T helper (Th)1 and Th2 cytokines. Interleukin-18, originally found as interferon-gamma-inducing factor, has now been identified to be involved in the development of Th1 and Th2 cells, which suggests the considerable involvement of this cytokine in the protective immune responses against infection. This review focuses on the role of interleukin-18 in the development and regulation of host resistance to infectious pathogens, with an emphasis on the infection with Cryptococcus neoformans, an intracellular fungal pathogen, as determined by recent studies from our laboratory.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048346     DOI: 10.1097/00002371-200203001-00003

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  3 in total

Review 1.  Interleukin 18 in the CNS.

Authors:  Silvia Alboni; Davide Cervia; Shuei Sugama; Bruno Conti
Journal:  J Neuroinflammation       Date:  2010-01-29       Impact factor: 8.322

2.  Rabies virus stimulates nitric oxide production and CXC chemokine ligand 10 expression in macrophages through activation of extracellular signal-regulated kinases 1 and 2.

Authors:  Kazuo Nakamichi; Satoshi Inoue; Tomohiko Takasaki; Kinjiro Morimoto; Ichiro Kurane
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  Association between interleukin-18 gene polymorphism and Helicobacter pylori infection in the Korean population.

Authors:  Dae-Seong Myung; Wan-Sik Lee; Young-Lan Park; Nuri Kim; Hyung-Hoon Oh; Mi-Young Kim; Chan-Young Oak; Cho-Yun Chung; Hyung-Chul Park; Jong-Sun Kim; Sung-Bum Cho; Sun-Seog Kweon; Young-Eun Joo
Journal:  Sci Rep       Date:  2015-06-22       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.